Showing results (211-220 of 225) with videos related to
Sort By:
Pageof 23
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 2, 2010
Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbancesAbigail Polter, Eléonore Beurel, Sufen Yang, et al.Bioinformation|June 29, 2007
An adaptive alpha spending algorithm improves the power of statistical inference in microarray data analysisJacob P L Brand, Lang Chen, Xiangqin Cui, et al.Cancer|December 1, 1981
Subcategories of histiocytic lymphoma: associations with survival and reproducibility of classification. The Southeastern Cancer Study Group experienceC C Whitcomb, J B Cousar, A Flint, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocolC R Nichols, S D Williams, P J Loehrer, et al.Journal of the American Optometric Association|January 1, 1997
Association between visual reaction time and batting, fielding, and earned run averages among players of the Southern Baseball LeagueJ G Classé, L P Semes, K M Daum, et al.Blood|July 1, 1983
Malignant lymphoma, mixed cell type, diffuseB N Nathwani, G E Metter, R A Gams, et al.Lupus|May 26, 1999
Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. NurtureG S Alarcón, A W Friedman, K V Straaton, et al.Annals of Surgery|September 1, 1993
Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trialC M Balch, M M Urist, C P Karakousis, et al.Cancer|January 1, 1995
A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanomaM K Wallack, M Sivanandham, C M Balch, et al.Journal of the American College of Surgeons|July 11, 1998
Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trialM K Wallack, M Sivanandham, C M Balch, et al.Pageof 23